Literature DB >> 21447487

Effects of propofol on the expression of matric metalloproteinases in rat cardiac fibroblasts after hypoxia and reoxygenation.

J H Jun1, J E Cho, Y H Shim, J K Shim, Y L Kwak.   

Abstract

BACKGROUND: Propofol is known to protect the myocardium against ischaemia/reperfusion (I/R) injury through its antioxidant and anti-inflammatory properties. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are involved in cell migration and invasion, and mediate tissue remodelling during I/R injury. They are regulated by various mechanisms including oxidative stress and AKT and ERK pathways. We investigated whether propofol affected the expression of MMPs and subsequent cell migration and invasion and the signalling pathways involved in primary rat cardiac fibroblasts undergoing hypoxia and reoxygenation.
METHODS: The phosphorylation of ERK and AKT signalling pathways was examined by western blot analysis in rat primary cardiac fibroblasts after hypoxia and reoxygenation. mRNA expression of MMP and TIMPS was analysed by real-time PCR, and proteolytic activities of MMP-2 and -9 were assessed. The effects of propofol on migration, invasion, wound healing, and cell proliferation activity were evaluated after reoxygenation.
RESULTS: Propofol induced AKT and ERK1/2 activation. Subsequent activation of MMPs resulted in increased cell migration, invasion, and wound-healing activity under hypoxia-reoxygenation, which was decreased by LY294002 (AKT inhibitor) and U0126 (ERK inhibitor) in rat cardiac fibroblasts. However, propofol had no effect on proliferation or viability of cardiac fibroblasts after hypoxia-reoxygenation.
CONCLUSIONS: Propofol affected the expression of MMPs and TIMPs and subsequently induced cell migration and invasive ability, through activation of the ERK and AKT signalling pathway in hypoxia-reoxygenated rat cardiac fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447487     DOI: 10.1093/bja/aer006

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

1.  Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection.

Authors:  Péter Bencsik; Krisztina Kupai; Anikó Görbe; Éva Kenyeres; Zoltán V Varga; János Pálóczi; Renáta Gáspár; László Kovács; Lutz Weber; Ferenc Takács; István Hajdú; Gabriella Fabó; Sándor Cseh; László Barna; Tamás Csont; Csaba Csonka; György Dormán; Péter Ferdinandy
Journal:  Front Pharmacol       Date:  2018-04-05       Impact factor: 5.810

2.  Exosomal lncRNA AK139128 Derived from Hypoxic Cardiomyocytes Promotes Apoptosis and Inhibits Cell Proliferation in Cardiac Fibroblasts.

Authors:  Lei Wang; Jun Zhang
Journal:  Int J Nanomedicine       Date:  2020-05-12

3.  Protection against Doxorubicin-Induced Cardiotoxicity through Modulating iNOS/ARG 2 Balance by Electroacupuncture at PC6.

Authors:  Jingya Wang; Lin Yao; Xiaoli Wu; Qi Guo; Shengxuan Sun; Jie Li; Guoqi Shi; Ruth B Caldwell; R William Caldwell; Yongjun Chen
Journal:  Oxid Med Cell Longev       Date:  2021-03-20       Impact factor: 6.543

4.  Ginsenoside RK3 Prevents Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes via AKT and MAPK Pathway.

Authors:  Jing Sun; Guibo Sun; Xiangbao Meng; Hongwei Wang; Min Wang; Meng Qin; Bo Ma; Yun Luo; Yingli Yu; Rongchang Chen; Qidi Ai; Xiaobo Sun
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-27       Impact factor: 2.629

5.  Propofol attenuates hydrogenperoxide-induced apoptosis in human umbilical vein endothelial cells via multiple signaling pathways.

Authors:  Cheng Lan Xie; Yin Bing Pan; Liu Qing Hu; Yan Ning Qian
Journal:  Korean J Anesthesiol       Date:  2015-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.